Medical Device Innovation: A design and development one-on-one with ATDC Lead Entrepreneur in Residence Frank Tighe and GCMI CEO Tiffany Wilson

The design and development process can make or break a medical device’s commercial potential. It is dependent on careful consideration of several intersecting aspects: technological, clinical, commercial and legal. Too many promising medtech innovations and early stage companies fail unnecessarily because they run out of funding before achieving milestones required for next-round investments. Medical device…

Aftermath: Three top reasons new medtech development projects fail and ways to avoid them.

Medtech innovation is an exciting, yet risky enterprise. The vast majority of venture capital and strategic investors now want to see early investment in de-risking medical innovations. There is simply too much potential for failure in the pathway to commercialization, plus financial risk related to market forces and competitive products.   Too many medtech development…

Collaboration in Action: How Georgia Tech faculty and the Flowers Invention Studio used GCMI and the Atlanta medtech ecosystem to bring desperately needed PPE to frontline healthcare workers.

In mid-March 2020, the shortage of personal protective equipment for healthcare providers responding to the COVID-19 outbreak had become a national emergency. By the time the University System of Georgia suspended on-campus instruction and asked students to depart campus by March 13 in response to rapidly increasing numbers of COVID-19 cases, Christopher Saldana, Ph.D., associate…

Webinar: How to design an efficient preclinical protocol

Preclinical work, especially GLP studies, are costly and critical to the product’s successful regulatory submission. Efficiency and quality in preclinical work begins with a robust preclinical study protocol. Preclinical protocols are the foundation on which reports required by regulatory bodies are built.   What elements in a preclinical study protocol give the study the best…

Aflac Incorporated Donates $5 Million, including $2 Million to GCMI, as Part of Company’s Overall COVID-19 Pandemic Response

Aflac Incorporated, a leader in supplemental insurance at U.S. worksites, today announced it has contributed $5 million to two organizations that are providing assistance for health care workers on the front lines of the COVID-19 global pandemic. The $5 million donation includes: $2 million for the Global Center for Medical Innovation (GCMI), a comprehensive innovation center using innovative 3D printing to help…

Proudly collaborating with Georgia Tech, Emory faculty and staff to support frontline healthcare workers in a time of crisis.

In one week, a team of students in a joint biotech medical lab with Georgia Tech and Emory students started making and distributing face shields to help save lives.   “The goal is to meet the needs locally to actually supply the Georgia Department of Public Health and when they have enough to actually supply…

Delta Flight Products begins manufacturing process of GCMI-designed PPE

From the Delta News Hub: April 2, 2020: Delta Flight Products, the airline’s wholly owned subsidiary, is collaborating with Global Center for Medical Innovation (GCMI), a non-profit affiliate of the Georgia Institute of Technology, to manufacture face shields to protect hospital workers during the COVID-19 pandemic. Using materials and designs provided by GCMI, Delta Flight…

GCMI Joins ExxonMobil to Accelerate Innovation for Personal Protective Equipment

“In response to the unprecedented challenges from the COVID-19 pandemic, ExxonMobil is applying its deep knowledge and experience with polymer-based technologies in combination with GCMI to facilitate development and expedite third-party production of innovative safety equipment that can be sterilized and worn multiple times.   “A new industrial-style mask is being fast-tracked for production. The…

Medical Design & Outsourcing: FDA issues FAQ on 3D-printed equipment against coronavirus

Earlier today Medical Design & Outsourcing published the following from the FDA regarding 3D printed equipment intended to supplement PPE needs created by the ongoing COVID-19 pandemic. “University research teams and others have been racing to develop DIY ventilators to help patients whose breathing is restricted by COVID-19. Those seeking to 3D-print accessories or parts…